You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
仁和藥業(000650.SZ):擬以7.19億元收購深圳三浦天然化粧品等7家公司各80%股權
格隆匯 07-06 17:58

格隆匯7月6日丨仁和藥業(000650.SZ)公佈,公司擬以自有資金71949.6萬元人民幣的價收購深圳市浦天然化粧品有限公司、江西電子商務有限公司江西聚優美電子商務有限公司、江西美之妙電子商務有限公司、江西合和實業有限公司、江西仁和大健康科技有限公司、江西金衡康生物科技有限公司(以下簡稱:標的公司)80%的股權。

深圳市浦天然化粧品有限公司公司的關係為同一最終控制方,根據深圳證券交易所《股票上市規則》及《公司章程》的規定,交易構成關聯交易,其餘六家標的公司因部分自於關聯公司深圳市浦天然化粧品有限公司,且品牌大部分使用的是“仁”商標,於謹慎性原則,收購以上七家標的公司80%股權交易全部按關聯交易審議程序操作,交應提交董事會審議後提交股東大會審議。

大健康產業是中國國民經濟的重要組件之一,是指和個人健康的維持、恢復以及增強相關的服務和產品,包括醫療服務、母嬰產品、營養和健康產品以及其他服務(健康管理和養老服務)等。人口老齡化速度加快及居民健康意識的提升,刺激了中國衞生消費需求,進而驅動大健康產業的發展。我國十三五規劃將建設健康中國上升為國家戰略,並明確指出,計劃到2020年,中國基本建立覆蓋全生命週期的健康服務業體系。在政策的大力扶持下,大健康產業規模將持續增長,並有望成為中國未來經濟增長的新引擎。

基於此,2021年是仁和五五規劃發展的開局之年,也是仁和事業創新發展過程中的關鍵之年。公司五五規劃明確指出在繼續保持公司OTC行業穩步增長的基礎上,加大加快大健康相關產業的發展,最終實現傳統OTC板塊與創新大健康板塊的雙輪驅動,進而推動公司健康、長遠的發展。此次公司與上述七家公司最終完成收購後,利於公司優化戰略佈局、豐富公司產品資源,擴大公產品的類品規,打造新的經濟增長點,不斷提高公司核心競爭力,符合公司中長期展規劃,符合全體股東和公司利益

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account